Persistence with teriparatide in patients with osteoporosis: the UK experience

  title={Persistence with teriparatide in patients with osteoporosis: the UK experience},
  author={Nigel K Arden and Sarah Earl and Dave J. Fisher and Cyrus Cooper and Scott Carruthers and M. Goater},
  journal={Osteoporosis International},
The objective of this paper was to determine the persistence with teriparatide at 12 months in all patients in the UK who were prescribed the treatment since its launch. Virtually all patients prescribed teriparatide in the UK receive treatment through Healthcare at Home, Basingstoke, UK. Data was obtained to assess the start date, discontinuation date and reason for discontinuation in all patients receiving teriparatide since its launch. Persistence was defined as the number of patients… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Explore Further: Topics Discussed in This Paper


Publications citing this paper.
Showing 1-10 of 27 extracted citations

Safety of osteoanabolic therapy: a decade of experience.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research • 2012
View 9 Excerpts
Highly Influenced

Teriparatide in men: persistence and geographical variation in the UK

Osteoporosis International • 2008
View 3 Excerpts
Highly Influenced


Publications referenced by this paper.
Showing 1-10 of 11 references

Assessment of adherence and persistence with daily and weekly dosing regimens of oral bisphosphonates

SJ Bocuzzi, SH Folz, MA Omar, KH Kahler
Osteoporos Int 16(Suppl • 2005
View 2 Excerpts

Similar Papers

Loading similar papers…